Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| STEPAN COSCL · Entity 4733 | Director · President & CEO | March 08, 2024 | March 11, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
STEPAN CO
Report date March 08, 2024 · Filed March 11, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,418.404 |
Reported balance
After 2024-03-08 transaction · row 1
1 source rowRow 1 · 2024-03-08 · Tax withholding · Disposed 647 · Balance 14,418.404 F1: The transaction reported reflects the withholding of shares from the performance shares vested on February 15, 2024. Withholding of these shares was applied to the reporting person's account on the transaction date shown. |
Filing footnotes · ownership attribution and instrument terms
F1: The transaction reported reflects the withholding of shares from the performance shares vested on February 15, 2024. Withholding of these shares was applied to the reporting person's account on the transaction date shown.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 29, 2019 Filed Jul 31, 2019 21:16 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,851 | $0.00 Strike: $41.16 | $0.00 |
DisclosureSEC source: 0001127602-19-025548 · form4.xml · derivative · entry 16 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,851 shares Expires 2025-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 21:16 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionStock Appreciation Right · Derivative | 6,262 | $0.00 Strike: $43.85 | $0.00 |
DisclosureSEC source: 0001127602-19-025548 · form4.xml · derivative · entry 15 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,262 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 21:16 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionStock Appreciation Right · Derivative | 2,000 | $0.00 Strike: $43.85 | $0.00 |
DisclosureSEC source: 0001127602-19-025548 · form4.xml · derivative · entry 14 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,262 Underlying: Common Stock · 2,000 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 21:16 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,298 | $0.00 Strike: $42.77 | $0.00 |
DisclosureSEC source: 0001127602-19-025548 · form4.xml · derivative · entry 13 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,298 shares Expires 2022-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 21:16 UTC | STEPAN CO SCL · Entity 4733 | SaleCommon Stock | 4,389 | $98.95 | $434,291.55 |
DisclosureSEC source: 0001127602-19-025548 · form4.xml · nonDerivative · entry 10 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,676.913 F5 · kind: The price reported is a weighted average price. Shares were sold in a series of transactions within the same trading day at prices ranging from $98.705 to $99.210, inclusive. Full information regarding the number of shares sold at each separate price is available upon request by the Commission staff, the issuer, or a security holder of the issuer. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 21:16 UTC | STEPAN CO SCL · Entity 4733 | SaleCommon Stock | 2,701 | $98.29 | $265,486.69 |
DisclosureSEC source: 0001127602-19-025548 · form4.xml · nonDerivative · entry 9 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,065.913 F4 · kind: The price reported is a weighted average price. Shares were sold in a series of transactions within the same trading day at prices ranging from $97.700 to $98.700, inclusive. Full information regarding the number of shares sold at each separate price is available upon request by the Commission staff, the issuer, or a security holder of the issuer. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 21:16 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 3,851 | $41.16 | $158,507.16 |
DisclosureSEC source: 0001127602-19-025548 · form4.xml · nonDerivative · entry 8 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,766.913 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 21:16 UTC | STEPAN CO SCL · Entity 4733 | Tax withholdingCommon Stock | 1,545 | $98.93 | $152,839.13 |
DisclosureSEC source: 0001127602-19-025548 · form4.xml · nonDerivative · entry 7 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,915.913 F3 · kind: Withholding of shares to satisfy tax liability on exercise of SARs. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 21:16 UTC | STEPAN CO SCL · Entity 4733 | Disposition to issuerCommon Stock | 2,776 | $98.93 | $274,615.80 |
DisclosureSEC source: 0001127602-19-025548 · form4.xml · nonDerivative · entry 6 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,460.913 F2 · kind: Deemed disposition of underlying common stock to the issuer in an amount equal to the conversion price of the SARs. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 21:16 UTC | STEPAN CO SCL · Entity 4733 | Tax withholdingCommon Stock | 494 | $99.00 | $48,906.00 |
DisclosureSEC source: 0001127602-19-025548 · form4.xml · nonDerivative · entry 5 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,236.913 F3 · kind: Withholding of shares to satisfy tax liability on exercise of SARs. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 21:16 UTC | STEPAN CO SCL · Entity 4733 | Disposition to issuerCommon Stock | 886 | $99.00 | $87,714.00 |
DisclosureSEC source: 0001127602-19-025548 · form4.xml · nonDerivative · entry 4 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,730.913 F2 · kind: Deemed disposition of underlying common stock to the issuer in an amount equal to the conversion price of the SARs. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 21:16 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 6,262 | $43.85 | $274,588.70 |
DisclosureSEC source: 0001127602-19-025548 · form4.xml · nonDerivative · entry 3 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,616.913 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The Stock Appreciation Rights ("SARs") were settled in shares of common stock as per the terms of the award. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 21:16 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 2,000 | $43.85 | $87,700.00 |
DisclosureSEC source: 0001127602-19-025548 · form4.xml · nonDerivative · entry 2 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,354.913 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The Stock Appreciation Rights ("SARs") were settled in shares of common stock as per the terms of the award. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 21:16 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 1,298 | $42.77 | $55,508.97 |
DisclosureSEC source: 0001127602-19-025548 · form4.xml · nonDerivative · entry 1 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,354.913 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 26, 2019 Filed Jul 29, 2019 20:49 UTC | STEPAN CO SCL · Entity 4733 | SaleCommon Stock | 2,004 | $97.39 | $195,163.55 |
DisclosureSEC source: 0001127602-19-025350 · form4.xml · nonDerivative · entry 7 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,056.913 F4 · price: The price reported is a weighted average price. Shares were sold in a series of transactions within the same trading day at prices ranging from $97.290 to $97.790, inclusive. Full information regarding the number of shares sold at each separate price is available upon request by the Commission staff, the issuer, or a security holder of the issuer. Read SEC document |
| July 25, 2019 Filed Jul 29, 2019 20:49 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionStock Appreciation Right · Derivative | 2,000 | $0.00 Strike: $43.85 | $0.00 |
DisclosureSEC source: 0001127602-19-025350 · form4.xml · derivative · entry 10 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,262 Underlying: Common Stock · 2,000 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 25, 2019 Filed Jul 29, 2019 20:49 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionStock Appreciation Right · Derivative | 2,000 | $0.00 Strike: $43.85 | $0.00 |
DisclosureSEC source: 0001127602-19-025350 · form4.xml · derivative · entry 9 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,262 Underlying: Common Stock · 2,000 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 25, 2019 Filed Jul 29, 2019 20:49 UTC | STEPAN CO SCL · Entity 4733 | Tax withholdingCommon Stock | 492 | $98.50 | $48,462.00 |
DisclosureSEC source: 0001127602-19-025350 · form4.xml · nonDerivative · entry 6 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,060.913 F3 · kind: Withholding of shares to satisfy tax liability on exercise of SARs. Read SEC document |
| July 25, 2019 Filed Jul 29, 2019 20:49 UTC | STEPAN CO SCL · Entity 4733 | Disposition to issuerCommon Stock | 890 | $98.50 | $87,665.00 |
DisclosureSEC source: 0001127602-19-025350 · form4.xml · nonDerivative · entry 5 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,552.913 F2 · kind: Deemed disposition of underlying common stock to the issuer in an amount equal to the conversion price of the SARs. Read SEC document |
| July 25, 2019 Filed Jul 29, 2019 20:49 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 2,000 | $43.85 | $87,700.00 |
DisclosureSEC source: 0001127602-19-025350 · form4.xml · nonDerivative · entry 4 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,442.913 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The Stock Appreciation Rights ("SARs") were settled in shares of common stock as per the terms of the award. Read SEC document |
| July 25, 2019 Filed Jul 29, 2019 20:49 UTC | STEPAN CO SCL · Entity 4733 | Tax withholdingCommon Stock | 492 | $98.50 | $48,462.00 |
DisclosureSEC source: 0001127602-19-025350 · form4.xml · nonDerivative · entry 3 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,442.913 F3 · kind: Withholding of shares to satisfy tax liability on exercise of SARs. Read SEC document |
| July 25, 2019 Filed Jul 29, 2019 20:49 UTC | STEPAN CO SCL · Entity 4733 | Disposition to issuerCommon Stock | 890 | $98.50 | $87,665.00 |
DisclosureSEC source: 0001127602-19-025350 · form4.xml · nonDerivative · entry 2 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,934.913 F2 · kind: Deemed disposition of underlying common stock to the issuer in an amount equal to the conversion price of the SARs. Read SEC document |
| July 25, 2019 Filed Jul 29, 2019 20:49 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 2,000 | $43.85 | $87,700.00 |
DisclosureSEC source: 0001127602-19-025350 · form4.xml · nonDerivative · entry 1 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,824.913 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The Stock Appreciation Rights ("SARs") were settled in shares of common stock as per the terms of the award. Read SEC document |
| June 14, 2019 Filed Jun 18, 2019 20:49 UTC | STEPAN CO SCL · Entity 4733 | GrantShare Units · Derivative | 24.209 | $91.76 | $2,221.42 |
DisclosureSEC source: 0001127602-19-022029 · form4.xml · derivative · entry 5 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,909.771 Underlying: Common Stock · 24.209 shares Expires not disclosed F3 · security: Share Units are acquired under the Management Incentive Plan (As Amended and Restated Effective January 1, 2015) ("MIP"), a nonqualified deferred compensation plan which allows MIP participants to elect to defer all or a portion of their deferred compensation into accounts pursuant to MIP provisions. F4 · derivative.exercise_price: Share Units convert on a one-for-one basis into Common Stock. F6 · price: Price reported is the price of Common Stock on the date the dividend equivalents are payable pursuant to a dividend equivalent feature of the MIP. F5 · derivative.exercise_date: Reflects acquisition of Share Units pursuant to a dividend equivalent feature of the MIP, generally payable at end of employment, unless otherwise elected. F5 · derivative.expiration_date: Reflects acquisition of Share Units pursuant to a dividend equivalent feature of the MIP, generally payable at end of employment, unless otherwise elected. Read SEC document |
| June 14, 2019 Filed Jun 18, 2019 20:49 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 28.008 | $91.76 | $2,570.01 |
DisclosureSEC source: 0001127602-19-022029 · form4.xml · nonDerivative · entry 2 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,824.913 F1 · kind: Reflects acquisition of deferred share units under the Performance Award Deferred Compensation Plan ("Plan") pursuant to a dividend equivalent feature of the Plan. Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 18:37 UTC | STEPAN CO SCL · Entity 4733 | SaleCommon Stock | 2,000 | $89.78 | $179,569.00 |
DisclosureSEC source: 0001127602-19-012088 · form4.xml · nonDerivative · entry 1 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,768.119 F1 · price: The price reported is a weighted average price. Shares were sold in a series of transactions within the same trading day at prices ranging from $88.890 to $90.630, inclusive. Full information regarding the number of shares sold at each separate price is available upon request by the Commission staff, the issuer, or a security holder of the issuer. Read SEC document |
| March 15, 2019 Filed Jun 18, 2019 20:49 UTC | STEPAN CO SCL · Entity 4733 | GrantShare Units · Derivative | 24.881 | $89.03 | $2,215.16 |
DisclosureSEC source: 0001127602-19-022029 · form4.xml · derivative · entry 4 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,885.562 Underlying: Common Stock · 24.881 shares Expires not disclosed F3 · security: Share Units are acquired under the Management Incentive Plan (As Amended and Restated Effective January 1, 2015) ("MIP"), a nonqualified deferred compensation plan which allows MIP participants to elect to defer all or a portion of their deferred compensation into accounts pursuant to MIP provisions. F4 · derivative.exercise_price: Share Units convert on a one-for-one basis into Common Stock. F6 · price: Price reported is the price of Common Stock on the date the dividend equivalents are payable pursuant to a dividend equivalent feature of the MIP. F5 · derivative.exercise_date: Reflects acquisition of Share Units pursuant to a dividend equivalent feature of the MIP, generally payable at end of employment, unless otherwise elected. F5 · derivative.expiration_date: Reflects acquisition of Share Units pursuant to a dividend equivalent feature of the MIP, generally payable at end of employment, unless otherwise elected. Read SEC document |
| March 15, 2019 Filed Jun 18, 2019 20:49 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 28.786 | $89.03 | $2,562.82 |
DisclosureSEC source: 0001127602-19-022029 · form4.xml · nonDerivative · entry 1 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,796.905 F1 · kind: Reflects acquisition of deferred share units under the Performance Award Deferred Compensation Plan ("Plan") pursuant to a dividend equivalent feature of the Plan. Read SEC document |
| March 11, 2019 Filed Mar 13, 2019 18:54 UTC | STEPAN CO SCL · Entity 4733 | SaleCommon Stock | 2,000 | $91.24 | $182,484.00 |
DisclosureSEC source: 0001127602-19-011222 · form4.xml · nonDerivative · entry 1 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,768.119 F1 · price: The price reported is a weighted average price. Shares were sold in a series of transactions within the same trading day at prices ranging from $90.80 to $91.56, inclusive. Full information regarding the number of shares sold at each separate price is available upon request by the Commission staff, the issuer, or a security holder of the issuer. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:09 UTC | STEPAN CO SCL · Entity 4733 | Tax withholdingCommon Stock | 1,976 | $93.43 | $184,617.68 |
DisclosureSEC source: 0001127602-19-010280 · form4.xml · nonDerivative · entry 1 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,768.119 F1 · kind: The transaction reported reflects the withholding of shares from the performance shares vested on February 20, 2019 which were reported on the Form 4 filed for the reporting person on February 22, 2019. Withholding of these shares were applied to the reporting person's account on the transaction date shown. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 20:01 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionStock Appreciation Right · Derivative | 2,000 | $0.00 Strike: $41.16 | $0.00 |
DisclosureSEC source: 0001127602-19-008655 · form4.xml · derivative · entry 12 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2025-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The SARs were settled in shares of common stock as per the terms of the award. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 20:01 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionStock Appreciation Right · Derivative | 996 | $0.00 Strike: $58.22 | $0.00 |
DisclosureSEC source: 0001127602-19-008655 · form4.xml · derivative · entry 11 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 996 shares Expires 2024-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 20:01 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionStock Appreciation Right · Derivative | 2,360 | $0.00 Strike: $61.91 | $0.00 |
DisclosureSEC source: 0001127602-19-008655 · form4.xml · derivative · entry 10 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,360 shares Expires 2024-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 20:01 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionStock Appreciation Right · Derivative | 1,813 | $0.00 Strike: $63.11 | $0.00 |
DisclosureSEC source: 0001127602-19-008655 · form4.xml · derivative · entry 9 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,813 shares Expires 2023-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 20:01 UTC | STEPAN CO SCL · Entity 4733 | Tax withholdingCommon Stock | 375 | $94.14 | $35,302.50 |
DisclosureSEC source: 0001127602-19-008655 · form4.xml · nonDerivative · entry 7 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,913.119 F5 · kind: Withholding of shares to satisfy tax liability on exercise of SARs. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 20:01 UTC | STEPAN CO SCL · Entity 4733 | Disposition to issuerCommon Stock | 875 | $94.14 | $82,372.50 |
DisclosureSEC source: 0001127602-19-008655 · form4.xml · nonDerivative · entry 6 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,288.119 F4 · kind: Deemed disposition of underlying common stock to the issuer in an amount equal to the conversion price of the SARs. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 20:01 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 2,000 | $41.16 | $82,320.00 |
DisclosureSEC source: 0001127602-19-008655 · form4.xml · nonDerivative · entry 5 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,163.119 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The SARs were settled in shares of common stock as per the terms of the award. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 20:01 UTC | STEPAN CO SCL · Entity 4733 | Disposition to issuerCommon Stock | 5,169 | $94.38 | $487,859.01 |
DisclosureSEC source: 0001127602-19-008655 · form4.xml · nonDerivative · entry 4 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,744.119 F1 · kind: The stock appreciation rights ("SARs") were settled in cash as per the terms of the award. For reporting purposes, however, the transaction is deemed to be a simultaneous acquisition and disposition of the underlying common stock and is reflected as such in this report. F2 · price: The price reported is a weighted average price. Shares were sold in a series of transactions within the same trading day at prices ranging from $94.27 to $94.48, inclusive. Full information regarding the number of shares sold at each separate price is available upon request by the Commission staff, the issuer, or a security holder of the issuer. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 20:01 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 996 | $58.22 | $57,987.12 |
DisclosureSEC source: 0001127602-19-008655 · form4.xml · nonDerivative · entry 3 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,163.119 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 20:01 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 2,360 | $61.91 | $146,107.60 |
DisclosureSEC source: 0001127602-19-008655 · form4.xml · nonDerivative · entry 2 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,167.119 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 20:01 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 1,813 | $63.11 | $114,418.43 |
DisclosureSEC source: 0001127602-19-008655 · form4.xml · nonDerivative · entry 1 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,807.119 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:50 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionPerformance Shares · Derivative | 3,649 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007751 · form4.xml · derivative · entry 6 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,649 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2018. F1 · price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2018. F4 · derivative.exercise_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2018. F4 · derivative.expiration_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2018. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:50 UTC | STEPAN CO SCL · Entity 4733 | GrantPerformance Shares · Derivative | 2,601 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007751 · form4.xml · derivative · entry 5 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,601 Underlying: Common Stock · 2,601 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. F3 · price: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. F3 · derivative.exercise_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. F3 · derivative.expiration_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:50 UTC | STEPAN CO SCL · Entity 4733 | GrantStock Appreciation Right · Derivative | 10,124 | $0.00 Strike: $92.29 | $0.00 |
DisclosureSEC source: 0001127602-19-007751 · form4.xml · derivative · entry 4 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,124 Underlying: Common Stock · 10,124 shares Expires 2029-02-19 F2 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:50 UTC | STEPAN CO SCL · Entity 4733 | GrantStock Option (Right to Buy) · Derivative | 3,375 | $0.00 Strike: $92.29 | $0.00 |
DisclosureSEC source: 0001127602-19-007751 · form4.xml · derivative · entry 3 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,375 Underlying: Common Stock · 3,375 shares Expires 2029-02-19 F2 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:50 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 81.636 | $92.29 | $7,534.19 |
DisclosureSEC source: 0001127602-19-007751 · form4.xml · nonDerivative · entry 2 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Indirect · By Esop II Trust Disclosed balance after: 3,592.195 Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:50 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 6,744 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007751 · form4.xml · nonDerivative · entry 1 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,994.119 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2018. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 22:37 UTC | STEPAN CO SCL · Entity 4733 | GrantShare Units · Derivative | 28.583 | $77.25 | $2,208.04 |
DisclosureSEC source: 0001127602-18-036642 · form4.xml · derivative · entry 3 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,860.681 Underlying: Common Stock · 28.583 shares Expires not disclosed F3 · security: Share Units are acquired under the Management Incentive Plan (As Amended and Restated Effective January 1, 2015) ("MIP"), a nonqualified deferred compensation plan which allows MIP participants to elect to defer all or a portion of their deferred compensation into accounts pursuant to MIP provisions. F4 · derivative.exercise_price: Share Units convert on a one-for-one basis into Common Stock. F6 · price: Price reported is the price of Common Stock on the date the dividend equivalents are payable pursuant to a dividend equivalent feature of the MIP. F5 · derivative.exercise_date: Reflects acquisition of Share Units pursuant to a dividend equivalent feature of the MIP, generally payable at end of employment, unless otherwise elected. F5 · derivative.expiration_date: Reflects acquisition of Share Units pursuant to a dividend equivalent feature of the MIP, generally payable at end of employment, unless otherwise elected. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 22:37 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 33.068 | $77.25 | $2,554.50 |
DisclosureSEC source: 0001127602-18-036642 · form4.xml · nonDerivative · entry 1 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,250.119 F1 · kind: Reflects acquisition of deferred share units under the Performance Award Deferred Compensation Plan ("Plan") pursuant to a dividend equivalent feature of the Plan. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 19:46 UTC | STEPAN CO SCL · Entity 4733 | GrantShare Units · Derivative | 22.088 | $89.74 | $1,982.18 |
DisclosureSEC source: 0001127602-18-027853 · form4.xml · derivative · entry 3 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,832.098 Underlying: Common Stock · 22.088 shares Expires not disclosed F3 · security: Share Units are acquired under the Management Incentive Plan (As Amended and Restated Effective January 1, 2015) ("MIP"), a nonqualified deferred compensation plan which allows MIP participants to elect to defer all or a portion of their deferred compensation into accounts pursuant to MIP provisions. F4 · derivative.exercise_price: Share Units convert on a one-for-one basis into Common Stock. F5 · derivative.exercise_date: Reflects acquisition of Share Units pursuant to a dividend equivalent feature of the MIP, generally payable at end of employment, unless otherwise elected. F5 · derivative.expiration_date: Reflects acquisition of Share Units pursuant to a dividend equivalent feature of the MIP, generally payable at end of employment, unless otherwise elected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.